Oric Pharmaceuticals Inc — Quarterly Dividends (NASDAQ:ORIC) | MetaTrader

Open full chart

Nachrichten

H.C. Wainwright eleva preço-alvo da ORIC Pharmaceuticals com avanço dos ensaios

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress

Oppenheimer reitera classificação Outperform para ações da ORIC com preço-alvo de US$ 15

Oppenheimer reiterates Outperform on ORIC stock, $15 target

Oric Pharmaceuticals registra novo prospecto de oferta no mercado de US$ 200 milhões

Oric Pharmaceuticals files new $200 million at-the-market offering prospectus

Diretor da Oric Pharmaceuticals, Heyman, vende ações no valor de US$ 80.430

Oric Pharmaceuticals director Heyman sells shares worth $80,430

ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)

Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80

H.C. Wainwright mantém recomendação de compra para ações da ORIC Pharmaceuticals

H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock